UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2025
Commission File Number: 001-42810
YD Bio Limited
(Exact name of registrant as specified in its
charter)
12F., No. 3, Xingnan St.,
Nangang Dist.,
Taipei City 115001, Taiwan
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
Exhibit 99.7 to this Report on Form 6-K shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
EXHIBIT INDEX
Exhibit
Number |
|
Description |
| 99.1 |
|
Unaudited Interim Financial Statements of YD Bio Limited |
| 99.2 |
|
Unaudited Interim Financial Statements of YD Biopharma Limited |
| 99.3 |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations of YD Biopharma Limited |
| 99.4 |
|
Unaudited Interim Financial Statements of Breeze Holdings Acquisition Corp.
|
| 99.5 |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations of Breeze Holdings Acquisition Corp. |
| 99.6 |
|
Unaudited Pro Forma Condensed Combined and Consolidated Financial Information |
| 99.7 |
|
Press Release dated September 30, 2025 |
| 101.INS |
|
Inline XBRL Instance Document |
| 101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 104 |
|
Cover Page Interactive Data File formatted as Inline XBRL and contained in Exhibit 101 |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
YD Bio Limited |
| |
|
|
| |
By: |
/s/ Edmund Hen |
| |
Name: |
Edmund Hen |
| |
Title: |
Chief Financial Officer |
Date: September 30, 2025
2
